2014

Morning Research on Express Scripts, Cigna, Coventry Health Care, and Health Net

LONDON, March 4, 2013 /PRNewswire/ --

The Dow Jones closed the week at 14,089.66,up 0.25 percent while NASDAQ was up 0.30 percent to close at 3,169.74. Similarly,S&P also ended at a positive note at 1,518.20,up 0.23 percent on Friday. Markets are now looking forward to touch new all time highs. However,there are concerns about the slowdown in economy due to spending cuts. Our research team took a look at Healthcare sector,whilst fine tuning to select a few key companies like Express Scripts Holding Company (NASDAQ: ESRX),Cigna Corporation (NYSE: CI),Coventry Health Care Inc. (NYSE: CVH) and Health Net Inc. (NYSE: HNT) from the Health Care Plans industry. StockCall has posted free technical research reports on ESRX CI CVH and HNT and these can be accessed by signing up at

http://www.stockcall.com/analysis

Express Scripts Holding Company shares were up for its latest trading session, on Friday, ending the day 0.76 percent higher at $57.36. The stock fell to an intra-day low of $56.16, while its intra-day high stood at $57.69. The company has gained more than 6 percent this year, compared to a gain of 6.45 percent for the S&P 500. The stock has strong support at around $55.69, as the stock shows bullish trend. Upon breaching this level the stock may tumble to $54.34. The stock is trading higher than its 20-day and 50-day moving averages. Express Scripts' first resistance level is at $58.21, while its second resistance level is at $61.95. Download the free report on ESRX upon registration at

http://www.StockCall.com/ESRX030413.pdf  

Cigna Corporation traded in the range of $57.53 and $58.60 in its latest trading session, on Friday, and ended the day at $58.26, down 0.34 percent. The stock's 52 weeks range stands at $39.01 and $62.22. The company has gained 31.81 percent of its value in the past 12 months, while it gained 8.98 percent so far in 2013. The stock is in a bullish mode and may find its first resistance level at $58.63.  Upon breaching this level, the stock may go as high as $60.82. It has traded 1.88 million shares in the session, in comparison to its usual volume of 1.98 million. It is trading below its 20-day moving average of $59.88. CI technical report can be accessed for free by signing up at

http://www.StockCall.com/CI030413.pdf

Shares of Coventry Health Care Inc. ended last Friday's trading session marginally up at $45.50, 0.31 percent higher. It traded 1.12 million shares during the session. The stock gained more than 1 percent this year, lagging behind the broad market. The stock has slipped from $45.62 resistance level. It has support at around $44.90 at the moment. Its second support level is at $44.25. Despite its upward movement, Coventry Health Care is still trading below its 20-day moving average price of $45.99. The stock's resistance level is at $45.78. The free report on CVH can be downloaded by signing up now at

http://www.StockCall.com/CVH030413.pdf

Health Net Inc.'s stock is in a bullish mode and is trading above its 20 days SMA of $25.56.  On Friday, it ended its latest trading session foe last week 0.58 percent lower at $25.59, and it oscillated in the range of $25.21 and $25.86 during the session. The stock trades at Price/Earnings ratio of 85.30. Health Net is expected to face its first resistance level at $25.75. Upon breaching this level, the stock's next resistance level is at $26.25. Free report on HNT can be accessed by registering at

http://www.StockCall.com/HNT030413.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com  

SOURCE StockCall.com




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.